Rule the world

Pfizer snuggles up to India’s prized vaccination programme

Step 1 - Convince the government to use the vaccine. Step 2 - Get it patented. And now, Pfizer paves the way for Step 3 -  Become the first patented vaccine the government will have to buy

mikado-1013877_1920-1920x1920.jpg

In a single stroke, the Indian Patent Office set the dominoes falling on 11 August when it granted $53-billion pharma major Pfizer a patent for a vaccine that can prevent pneumonia. On 28 September, Panacea Biotec was the first to cry foul. After working for over a decade, it was close to a breakthrough, planning to launch its own Pneumococcal Conjugate Vaccine (PCV) by 2020. It was relying on the government to buy its affordable version over Pfizer’s expensive one.

To access this post, you must purchase Monthly Recurring or Quarterly.

Read the full story. Subscribe for free.

Why subscribe? Let us explain.

Already Registered?

Related stories

More stories in /Analysis & /Healthcare

See all in Analysis & Healthcare

This story is for subscribers only.
Subscribe for free

Read the full story. Subscribe for free.

Why subscribe? Let us explain.

Or

Already Registered?

Questions?

What is The Ken?

The Ken is a subscription-driven media site. We write one story a day (weekdays only). These stories have sharp, original insights on technology, business, science and healthcare from India.

Why do I have to sign up to read your stories?

Our stories are not free. Well, some select stories are. But, a significant part of what we write at The Ken is for subscribers only. We put in a lot of effort and resources in writing our stories and believe that you must pay for good journalism.
Hence, our three plans. 1) The annual membership
2) The free sign up
3) The recurring quarterly subscription

On journalism and why you should pay for it, if you haven’t already seen it, here’s a great explainer from John Oliver.

So, one must pay for journalism?

Yes.

How many stories will I get if I take an annual membership?

200+ stories.

And, in the free sign up?

Four stories every month.

Do I get a refund?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am not getting my daily emails. Do I have to whitelist emails from The Ken?

An added benefit of your subscription (free/paid) are the daily personalised emails. These emails, at times, might end up in your spam/junk folder due to emojis, attachments or images. In case you’re not receiving these emails, it might help to whitelist us. If the problem still persists, write to us at support@the-ken.com.

Why am I unable to access the archives?

Full and unrestricted access to our archives is a feature of our annual membership.

My payment is not going through, what can I do?

Please write to us at support@the-ken.com detailing the payment error or queries.